Immunosuppresant compounds and compositions

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 7,939,519
App. No.: 12/024,992
Granted: May 10, 2011
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.

Claims (5)

1. A compound of the formula

or a pharmaceutically acceptable salt, or a prodrug, or stereoisomer thereof.

2. A pharmaceutical composition comprising

(i) a therapeutically effective amount of the compound of claim 1 or a pharmaceutically acceptable salt, or a prodrug, or stereoisomer thereof; and

(ii) a pharmaceutically acceptable excipient.

Assignments (4)

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2023

From: NOVARTIS AG

To: NOVARTIS PHARMACEUTICALS CORPORATION

Reel/Frame 064027/0208 →

MERGER AND CHANGE OF NAME Recorded Jan 27, 2016